The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Antipsychotic Drug Effects on Brain Morphology in First-Episode Psychosis
Abstract
BACKGROUND: Pathomorphologic brain changes occurring as early as first-episode schizophrenia have been extensively described. Longitudinal studies have demonstrated that these changes may be progressive and associated with clinical outcome. This raises the possibility that antipsychotics might alter such pathomorphologic progression in early-stage schizophrenia. OBJECTIVE: To test a priori hypotheses that olanzapine-treated patients have less change over time in whole brain gray matter volumes and lateral ventricle volumes than haloperidol-treated patients and that gray matter and lateral ventricle volume changes are associated with changes in psychopathology and neurocognition. DESIGN: Longitudinal, randomized, controlled, multisite, double-blind study. Patients treated and followed up for up to 104 weeks. Neurocognitive and magnetic resonance imaging (MRI) assessments performed at weeks 0 (baseline), 12, 24, 52, and 104. Mixed-models analyses with time-dependent covariates evaluated treatment effects on MRI end points and explored relationships between MRI, psychopathologic, and neurocognitive outcomes. SETTING: Fourteen academic medical centers (United States, 11; Canada, 1; Netherlands, 1; England, 1). PARTICIPANTS: Patients with first-episode psychosis (DSM-IV) and healthy volunteers. INTERVENTIONS: Random allocation to a conventional antipsychotic, haloperidol (2-20 mg/d), or an atypical antipsychotic, olanzapine (5-20 mg/d). MAIN OUTCOME MEASURES: Brain volume changes assessed by MRI. RESULTS: Of 263 randomized patients, 161 had baseline and at least 1 postbaseline MRI evaluation. Haloperidol-treated patients exhibited significant decreases in gray matter volume, whereas olanzapine-treated patients did not. A matched sample of healthy volunteers (n = 58) examined contemporaneously showed no change in gray matter volume. CONCLUSIONS: Patients with first-episode psychosis exhibited a significant between-treatment difference in MRI volume changes. Haloperidol was associated with significant reductions in gray matter volume, whereas olanzapine was not. Post hoc analyses suggested that treatment effects on brain volume and psychopathology of schizophrenia may be associated. The differential treatment effects on brain morphology could be due to haloperidol-associated toxicity or greater therapeutic effects of olanzapine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
(1976) · Medical Entomology and Zoology · Cited by 8,899
A review of MRI findings in schizophrenia
Shenton, M. E., Dickey, C. C., Frumin, M., & McCarley, R. W. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00163-3 · Cited by 2,346
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685
The neuropathology of schizophrenia
Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677
Dynamics of Gray Matter Loss in Alzheimer's Disease
Thompson, P. M., Hayashi, K. M., de Zubicaray, G., Janke, A. L., Rose, S. E., Semple, J., Herman, D., Hong, M. S., Dittmer, S. S., Doddrell, D. M., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00994.2003 · Cited by 1,132
Automated model-based tissue classification of MR images of the brain
Van Leemput, K., Maes, F., Vandermeulen, D., & Suetens, P. (1999) · IEEE Transactions on Medical Imaging · doi:10.1109/42.811270 · Cited by 1,024
The reduced neuropil hypothesis: a circuit based model of schizophrenia
Selemon, L. D., & Goldman-Rakic, P. S. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00281-9 · Cited by 909
Lawrie, S. M., & Abukmeil, S. S. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.172.2.110 · Cited by 843
Lewis, D. A., & Lieberman, J. A. (2000) · Neuron · doi:10.1016/s0896-6273(00)00111-2 · Cited by 811
Self-citationMcCarley, R. W., Wible, C. G., Frumin, M., Hirayasu, Y., Levitt, J. J., Fischer, I. A., & Shenton, M. E. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00018-9 · Cited by 729
Longitudinal study of brain morphology in first episode schizophrenia
Lieberman, J., Chakos, M., Wu, H., Alvir, J., Hoffman, E., Robinson, D., & Bilder, R. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01067-8 · Cited by 554
Self-citationGur, R. E., Cowell, P., Turetsky, B. I., Gallacher, F., Cannon, T., Bilker, W., & Gur, R. C. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.2.145 · Cited by 540
Ho, B.-C., Andreasen, N. C., Nopoulos, P., Arndt, S., Magnotta, V., & Flaum, M. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.6.585 · Cited by 536
DeLisi, L. E., Sakuma, M., Tew, W., Kushner, M., Hoff, A. L., & Grimson, R. (1997) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(97)00012-7 · Cited by 512
Is schizophrenia a neurodegenerative disorder? a clinical and neurobiological perspective
Lieberman, J. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00147-x · Cited by 483
Self-citationIs Schizophrenia a Progressive Neurodevelopmental Disorder? Toward a Unitary Pathogenetic Mechanism
Woods, B. T. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.12.1661 · Cited by 412
Lieberman, J. A., Tollefson, G., Tohen, M., Green, A. I., Gur, R. E., Kahn, R., McEvoy, J., Perkins, D., Sharma, T., Zipursky, R., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.8.1396 · Cited by 404
Self-citationBrain Volume Changes in First-Episode Schizophrenia: A 1-Year Follow-up Study
Cahn, W., Pol, H. E. H., Lems, E. B. T. E., van Haren, N. E. M., Schnack, H. G., van der Linden, J. A., Schothorst, P. F., van Engeland, H., & Kahn, R. S. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.11.1002 · Cited by 400
Rapoport, J. L., Giedd, J. N., Blumenthal, J., Hamburger, S., Jeffries, N., Fernandez, T., Nicolson, R., Bedwell, J., Lenane, M., Zijdenbos, A., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.7.649 · Cited by 388
Keefe, R. S. E., Seidman, L. J., Christensen, B. K., Hamer, R. M., Sharma, T., Sitskoorn, M. M., Lewine, R. R. J., Yurgelun-Todd, D. A., Gur, R. C., Tohen, M., et al. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.985 · Cited by 314
Self-citationCorson, P. W., Nopoulos, P., Miller, D. D., Arndt, S., & Andreasen, N. C. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.8.1200 · Cited by 254
Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine
Chakos, M., Lieberman, J., Alvir, J., Bilder, R., & Ashtari, M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90441-7 · Cited by 250
Self-citationBai, O., Chlan‐Fourney, J., Bowen, R., Keegan, D., & Li, X. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10440 · Cited by 239
Atypical neuroleptics stimulate neurogenesis in adult rat brain
Wakade, C. G., Mahadik, S. P., Waller, J. L., & Chiu, F. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10281 · Cited by 230
Ventricular Enlargement in Poor-Outcome Schizophrenia
Davis, K. L., Buchsbaum, M. S., Shihabuddin, L., Spiegel-Cohen, J., Metzger, M., Frecska, E., Keefe, R. S., & Powchik, P. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00553-2 · Cited by 200
Konradi, C., & Heckers, S. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01267-7 · Cited by 200
Effects of Chronic Haloperidol and Clozapine Treatment on Neurogenesis in the Adult Rat Hippocampus
Halim, N. D., Weickert, C. S., McClintock, B. W., Weinberger, D. R., & Lipska, B. K. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300422 · Cited by 189
Selemon, L. D., Lidow, M. S., & Goldman-Rakic, P. S. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00113-4 · Cited by 166
Effects of Antipsychotic Drugs on Neurogenesis in the Forebrain of the Adult Rat
Wang, H.-D., Dunnavant, F. D., Jarman, T., & Deutch, A. Y. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300449 · Cited by 162
A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia
Wood, S. J., Velakoulis, D., Smith, D. J., Bond, D. J., Stuart, G. W., McGorry, P. D., Brewer, W. J., Bridle, N., Eritaia, J., Desmond, P. M., et al. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00175-x · Cited by 154
Olanzapine and Clozapine Increase the GABAergic Neuroactive Steroid Allopregnanolone in Rodents
Marx, C. E., VanDoren, M. J., Duncan, G. E., Lieberman, J. A., & Morrow, A. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300015 · Cited by 148
Self-citationPost, A., Holsboer, F., & Behl, C. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08236.1998 · Cited by 146
The effects of haloperidol on synaptic patterns in the rat striatum
Benes, F. M., Paskevich, P. A., Davidson, J., & Domesick, V. B. (1985) · Brain Research · doi:10.1016/0006-8993(85)90532-3 · Cited by 126
Effect of Antipsychotics on Regional Cerebral Blood Flow Measured with Positron Emission Tomography
Miller, D. D. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00042-0 · Cited by 103
Striatal enlargement in rats chronically treated with neuroleptic
Chakos, M., Shirakawa, O., Lieberman, J. A., Lee, H., Bilder, R. M., & Tamminga, C. A. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00029-8 · Cited by 98
Self-citationDuncan, G. E., Miyamoto, S., Leipzig, J. N., & Lieberman, J. A. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39197-9 · Cited by 97
Self-citationWright, A. M., Bempong, J., Kirby, M. L., Barlow, R. L., & Bloomquist, J. R. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01551-5 · Cited by 85
Lahti, A. C., Holcomb, H. H., Weiler, M. A., Medoff, D. R., Frey, K., Hardin, M. G., & Tamminga, C. A. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300312 · Cited by 85
Lidow, M. S., Song, Z., Castner, S. A., Allen, P. B., Greengard, P., & Goldman‐Rakic, P. S. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01058-1 · Cited by 82
Fumagalli, F., Molteni, R., Roceri, M., Bedogni, F., Santero, R., Fossati, C., Gennarelli, M., Racagni, G., & Riva, M. A. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10609 · Cited by 81
Gogtay, N., Sporn, A. L., CLASEN, L. S., GREENSTEIN, D. K., Giedd, J. N., Lenane, M., Gochman, P., Zijdenbos, A. P., & Rapoport, J. L. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.3.569 · Cited by 69
Meshul, C. K., Janowsky, A. J., Casey, D. E., Stallbaumer, R. K., & Taylor, B. (1992) · Psychopharmacology · doi:10.1007/bf02253587 · Cited by 62
Multisite validation of image analysis methods: assessing intra- and intersite variability
Styner, M. A., Charles, H. C., Park, J. K., & Gerig, G. (2002) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.467167 · Cited by 55
Tardive dyskinesia and substrates of energy metabolism in CSF
GOFF, D. C., Tsai, G. E., Beal, M., & Coyle, J. T. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.12.1730 · Cited by 52
Cerebral metabolism and risperidone treatment in schizophrenia
Molina, V., Gispert, J. D., Reig, S., Sanz, J., Pascau, J., Santos, A., Palomo, T., & Desco, M. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00199-8 · Cited by 47
Mathalon, D. H., Sullivan, E. V., Lim, K. O., & Pfefferbaum, A. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.2.148
Cited by
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693
A Structural MRI Study of Human Brain Development from Birth to 2 Years
Knickmeyer, R. C., Gouttard, S., Kang, C., Evans, D., Wilber, K., Smith, J. K., Hamer, R. M., Lin, W., Gerig, G., & Gilmore, J. H. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3479-08.2008 · Cited by 1,151
Ho, B.-C., Andreasen, N. C., Ziebell, S., Pierson, R., & Magnotta, V. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.199 · Cited by 971
van Erp, T. G. M., Walton, E., Hibar, D. P., Schmaal, L., Jiang, W., Glahn, D. C., Pearlson, G. D., Yao, N., Fukunaga, M., Hashimoto, R., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.04.023 · Cited by 934
Toga, A. W., Thompson, P. M., & Sowell, E. R. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.01.007 · Cited by 872
Metadata
- Authors
- Lieberman, J. A.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2005-04-01
- Volume
- 62
- Issue
- 4
- Pages
- 361
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2145240519
- Cited by
- 801
- References
- 47
- FWCI
- 35.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.